Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.33 |
| ▸ | CHRNG | P07510 | 1/20 | 0.33 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.33 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | CHRND | Q07001 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21097351 | 1.00 | MAPT (0.37) | MAPTTDP1ALDH1A1CHRNA1CHRNG | |
| SCHEMBL21097363 | 0.83 | MAPT (0.31) | MAPTTDP1 | |
| SCHEMBL13954530 | 0.83 | PEPD (0.31) | MAPTTDP1 | |
| SCHEMBL21097362 | 0.83 | MAPT (0.31) | MAPTTDP1 | |
| SCHEMBL294107 | 0.82 | TSHR (0.40) | MAPTALDH1A1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL13078245 | 0.79 | CHRM2 (0.43) | MAPTALDH1A1SLC6A4 | |
| SCHEMBL22819216 | 0.79 | CHRM2 (0.43) | MAPTALDH1A1SLC6A4 | |
| SCHEMBL21097366 | 0.79 | MAPT (0.39) | MAPTTDP1ALDH1A1POLBNPSR1 | |
| SCHEMBL21097364 | 0.79 | MAPT (0.39) | MAPTTDP1ALDH1A1POLBNPSR1 | |
| SCHEMBL1245764 | 0.78 | SLC6A4 (0.37) | MAPTALDH1A1CHRNA1CHRNGITGA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10343974-B1 | Cyclohexanol ethers as mediterranean fruit fly attractants | The United States of America, as represented by The Secretary of America (US) | 2019-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343974-B1 | Cyclohexanol ethers as mediterranean fruit fly attractants | C3AR1, CERS2, C1S | MAPT 2922/4885TDP1 3865/4885ALDH1A1 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.